Viking Therapeutics, Inc.

SAN DIEGO, CA · Founded 2012 · CIK 0001607678 · Biotech · Public

Small-molecule and biologic therapeutics for obesity and metabolic disease

vikingtherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.7M
1 Form D · Jun 2017
112 months since last filing
Contracts
—
No federal contracts on record
Patents
40
10 granted · 30 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,656,038
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3293Oryn Therapeutics, Inc.——
3294Inflamma Therapeutics, LLC——
3295CELLCHORUS INC.——
3296Viking Therapeutics, Inc.—$3.7M
3297PHELIX THERAPEUTICS LLC——
3298Ferment Labs, Inc.—$900K
3299Rhamnolipid, Inc.—$1.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Matthew FoehrDirector
  • Brian LianDirector · Executive Officer
  • Lawson MacartneyDirector
  • Michael MorneauExecutive Officer
  • J. SingletonDirector
  • Stephen WebsterDirector

Patents

USPTO · 10 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.